Publications by authors named "Jonathan Busquets"

Claim this Profile
G
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses.
Courtney D DiNardo, Divij Verma, Natalia Baran, Tushar D Bhagat, Anna Skwarska, Jonathan Busquets

Nat Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLC25A51 decouples the mitochondrial NAD/NADH ratio to control proliferation of AML cells.
Mu-Jie Lu, Jonathan Busquets, Valeria Impedovo, Crystal N Wilson, Hsin-Ru Chan

Cell Metab· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Katie H Hurrish, Yongwei Su, Shraddha Patel, Cassandra L Ramage, Jianlei Zhao, Jonathan Busquets

Biochem Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.
Katie H Hurrish, Yongwei Su, Shraddha Patel, Cassandra L Ramage, Jenna L Carter, Jonathan Busquets

Res Sq· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells.
Xiyuan Lu, Lina Han, Jonathan Busquets, Meghan Collins, Alessia Lodi

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis